News

Shares of top-10 national homebuilder Century Communities (NYSE: CCS) got punished with a 9.7% loss through 10:10 a.m. ET on Thursday, despite beating analyst forecasts for both sales and earnings

A lot of bad stocks have taken it on the chin in recent months -- but the same can be said about a lot of good stocks, too. Now, there are plenty of potential winners in the rubble, and you don't

Shares of the embattled Swiss bank Credit Suisse Group (NYSE: CS) struggled today after the bank reported its third-quarter earnings and as management announced an ambitious new restructuring plan

Bristol Myers Squibb (NYSE: BMY) has been a top healthcare stock to own for decades. It had eight blockbuster drugs last year that generated more than $1 billion in annual revenue, including

Investors have fled the market in droves this year as fears of a recession, geopolitical tension, and 40-year-high inflation have brought about a pessimistic outlook on Wall Street. There's no doubt

The increasing likelihood of a global recession has caused financial markets to sour in 2022. Down 21% year to date, the S&P 500 index has fallen into a bear market. But not all sectors have fared

In this video, I will be going over Shopify's (NYSE: SHOP) third-quarter earnings report and will explain the good, the bad, and what to look out for in the coming quarters. Management sees 2022 as

One of the biggest risks that haunts pharmaceutical companies is the patent cliff. Once drugmakers lose patent exclusivity for an internally developed medicine, cheaper generics typically enter the

Investors haven't had much certainty lately about the prospects for the stock market and the broader global economy. With inflation, rising interest rates, and sluggish business conditions all

Walgreens Boots Alliance (NASDAQ: WBA) and CVS Health (NYSE: CVS) are the two biggest retail pharmacy chains in the U.S., but they haven't behaved similarly as investments over the past decade

Novavax (NASDAQ: NVAX) is a beaten-down COVID stock that has seen its shares plummet 85% since the start of the year. Mounting losses and drastically slashed guidance, plus a COVID-19 vaccine market

Forever is a long time, but some stocks have earned that kind of dedication from investors. In my portfolio, Realty Income (NYSE: O) and Procter & Gamble (NYSE: PG) stand out as stocks I plan to

Macroeconomic uncertainty has set the stock market on a downward trajectory. Tesla (NASDAQ: TSLA) and Sea Limited (NYSE: SE) have seen their share prices plunge 45% and 86%, respectively, and both

Gene editing refers to techniques that allow researchers to modify the DNA of various organisms. Given that it offers the potential to help discover innovative therapies, it isn't surprising that

If you've got $1,000 you can afford to invest in the stock market right now, this could be an ideal time to buy shares of top companies. And there's no safer place for dividend investors to put

Shares of apartment giant Equity Residential (NYSE: EQR) have plunged more than 30% this year. That sell-off has driven the real estate investment trust's dividend yield up to 3.9%.

What's odd is

Now is the time for investors to load up on dividend stocks. Yields are high, valuations are low, and investors who add income-generating stocks to their portfolios today could be setting themselves

Teladoc Health (NYSE: TDOC) disappointed investors with its first-quarter and second-quarter results earlier this year. But the third time's the charm.

The virtual care provider provided its

Audio-streaming veteran Spotify Technology (NYSE: SPOT) reported robust third-quarter results by most measures. The company added 7 million premium subscribers and 23 million monthly active users

Disney (NYSE: DIS) made headlines over the last few months for a variety of reasons. As an entertainment industry icon for nearly 100 years and with a market cap of $190 billion, the company is

Thursday brought a mix of news to stock market investors, some good and some bad, and it reflected the interesting dichotomy between two different areas of the market. On one hand, old-economy

Shares of Bionano Genomics (NASDAQ: BNGO) tumbled by more than 55% this year, but that hasn't led Wall Street analysts who follow the stock to walk back their year-ahead price estimates or change

Meta Platforms' (NASDAQ: META) metaverse is going in reverse. The Facebook parent issued a stinker of an earnings report Wednesday, missing expectations on nearly every key metric and offering